Equine metabolic syndrome: Role of the enteroinsular axis in the insulin response to oral carbohydrate. (April 2023)
- Record Type:
- Journal Article
- Title:
- Equine metabolic syndrome: Role of the enteroinsular axis in the insulin response to oral carbohydrate. (April 2023)
- Main Title:
- Equine metabolic syndrome: Role of the enteroinsular axis in the insulin response to oral carbohydrate
- Authors:
- de Laat, Melody A.
Fitzgerald, Danielle M. - Abstract:
- Abstract: Equine insulin dysregulation (ID) comprises amplified insulin responses to oral carbohydrates or insulin resistance, or both, which leads to sustained or periodic hyperinsulinaemia. Hyperinsulinaemia is important in horses because of its clear association with laminitis risk, and the gravity of this common sequela justifies the need for a better understanding of insulin and glucose homoeostasis in this species. Post-prandial hyperinsulinaemia is the more commonly identified component of ID and is diagnosed using tests that include an assessment of the gastrointestinal tract (GIT). There are several factors present in the GIT that either directly, or indirectly, enhance insulin secretion from the endocrine pancreas, and these factors are collectively referred to as the enteroinsular axis (EIA). A role for key components of the EIA, such as the incretin peptides glucagon-like peptide-1 and 2, in the pathophysiology of ID has been investigated in horses. By comparison, the function (and even existence) of many EIA peptides of potential importance, such as glicentin and oxyntomodulin, remains unexplored. The incretins that have been examined all increase insulin responses to oral carbohydrate through one or more mechanisms. This review presents what is known about the EIA in horses, and discusses how it might contribute to ID, then compares this to current understanding derived from the extensive studies undertaken in other species. Future directions for research areAbstract: Equine insulin dysregulation (ID) comprises amplified insulin responses to oral carbohydrates or insulin resistance, or both, which leads to sustained or periodic hyperinsulinaemia. Hyperinsulinaemia is important in horses because of its clear association with laminitis risk, and the gravity of this common sequela justifies the need for a better understanding of insulin and glucose homoeostasis in this species. Post-prandial hyperinsulinaemia is the more commonly identified component of ID and is diagnosed using tests that include an assessment of the gastrointestinal tract (GIT). There are several factors present in the GIT that either directly, or indirectly, enhance insulin secretion from the endocrine pancreas, and these factors are collectively referred to as the enteroinsular axis (EIA). A role for key components of the EIA, such as the incretin peptides glucagon-like peptide-1 and 2, in the pathophysiology of ID has been investigated in horses. By comparison, the function (and even existence) of many EIA peptides of potential importance, such as glicentin and oxyntomodulin, remains unexplored. The incretins that have been examined all increase insulin responses to oral carbohydrate through one or more mechanisms. This review presents what is known about the EIA in horses, and discusses how it might contribute to ID, then compares this to current understanding derived from the extensive studies undertaken in other species. Future directions for research are discussed and knowledge gaps that should be prioritised are suggested. Highlights: The connection between the gut and the pancreas is called the enteroinsular axis. The enteroinsular axis contributes to insulin dysregulation in horses. The incretins increase insulin responses to oral carbohydrate. Many potentially important enteroinsular peptides remain unexplored in horses. … (more)
- Is Part Of:
- Veterinary journal. Volume 294(2023)
- Journal:
- Veterinary journal
- Issue:
- Volume 294(2023)
- Issue Display:
- Volume 294, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 294
- Issue:
- 2023
- Issue Sort Value:
- 2023-0294-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-04
- Subjects:
- Glucagon-like peptide-1 -- Hyperinsulinaemia -- Incretin -- Insulin dysregulation -- Laminitis
Veterinary medicine -- Periodicals
636 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10900233 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tvjl.2023.105967 ↗
- Languages:
- English
- ISSNs:
- 1090-0233
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9228.600000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26836.xml